Challenges
Why Trials Fail
Clinical trials have a 90% failure rate, with most failures due to lack of efficacy or unexpected safety issues. Patient Analog technology addresses these failures by enabling better preclinical prediction and patient stratification.
90%
Clinical Trial Failure Rate
$2.6B
Average Drug Development Cost
10+ yrs
Development Timeline
Solutions
How We Help
Patient Stratification
Identify biomarkers that predict responders vs non-responders. Enrich trials with patients likely to benefit.
Virtual Populations
Simulate drug response across diverse virtual populations to predict trial outcomes before enrolling patients.
Endpoint Development
Validate translational biomarkers and develop surrogate endpoints that predict clinical benefit.
Dose Selection
Optimize dosing strategies with PBPK modeling and multi-organ safety/efficacy predictions.